Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting

T M Harris; A C Bowen; D C Holt; D S Sarovich; K Stevens; B J Currie; B P Howden; J R Carapetis; P M Giffard; S Y C Tong

doi:10.1016/j.cmi.2018.04.020

Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting

Clin Microbiol Infect. 2018 Sep;24(9):1027-1029. doi: 10.1016/j.cmi.2018.04.020. Epub 2018 May 1.

Authors

T M Harris¹, A C Bowen², D C Holt³, D S Sarovich⁴, K Stevens⁵, B J Currie¹, B P Howden⁵, J R Carapetis⁶, P M Giffard³, S Y C Tong⁷

Affiliations

¹ Menzies School of Health Research, Darwin, Northern Territory, Australia.
² Menzies School of Health Research, Darwin, Northern Territory, Australia; Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
³ Menzies School of Health Research, Darwin, Northern Territory, Australia; School of Health and Human Sciences, Charles Darwin University, Darwin, Northern Territory, Australia.
⁴ Menzies School of Health Research, Darwin, Northern Territory, Australia; Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
⁵ Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
⁶ Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
⁷ Menzies School of Health Research, Darwin, Northern Territory, Australia; Victorian Infectious Disease Service, The Royal Melbourne Hospital and The University of Melbourne, at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: [email protected].

PMID: 29723570
DOI: 10.1016/j.cmi.2018.04.020

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Australia / epidemiology
Drug Resistance, Bacterial*
Humans
Methicillin-Resistant Staphylococcus aureus / drug effects*
Methicillin-Resistant Staphylococcus aureus / genetics
Methicillin-Resistant Staphylococcus aureus / isolation & purification
Microbial Sensitivity Tests
Staphylococcal Infections / drug therapy
Staphylococcal Infections / epidemiology
Staphylococcal Infections / microbiology*
Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

Anti-Bacterial Agents
Trimethoprim, Sulfamethoxazole Drug Combination